Dova pharmaceuticals inc. (DOVA)
Income statement / Yearly
Dec'18Dec'17
Revenue
Revenue

10,355

0

Operating expenses:
Cost of product sales

1,180

0

Research and development

18,304

15,710

Selling, general and administrative

61,921

13,499

Total operating expenses

81,405

29,209

Loss from operations

-71,050

-29,209

Interest income and other income (expense), net

644

486

Interest expense

1,876

1,232

Total other expenses, net

-1,232

-746

Interest income and other income (expense), net

644

486

Net loss

-72,282

-29,955

Net loss per share, basic and diluted (in dollars per share)

-2.60

-1.40

Weighted average common shares outstanding, basic and diluted (in shares)

27,803

21,435

Product sales, net
Revenue

7,728

0

Other revenue
Revenue

2,627

0